Revenue

Jazz Pharma's lung cancer drug Zepzelca fails a key trial, raising regulatory questions. Yet its strength in another setting reveals a complex drug development system.

MBX Biosciences' new one-year data for canvuparatide isn't just a clinical win; it's a calculated move to dominate a billion-dollar market left vacant.

Hisense is using the FIFA World Cup to push its RGB MiniLED tech. But this is more than a sponsorship; it's a bid to redefine the global TV market.

With its new Series A, Aton Health isn't just growing; it's validating a model where research is seamlessly integrated into routine patient care.

With Bill C-34, Canada wants to make social media and AI safer for children. But can it balance protection with privacy and digital freedom?

Novartis unveils groundbreaking Phase III data for Rhapsido, offering hope as the first potential targeted therapy for 29 million chronic hive sufferers.

As Jones Soda prepares for the Planet MicroCap conference, its impressive financial rebound and bold diversification strategy take center stage for investors.

A new partnership aims to audit and verify tradable AI 'Skills.' We dissect how applying blockchain security principles could unlock a multi-billion dollar AI Agent economy.

With a new CMO, Get A Drip is capitalizing on the longevity trend. But as it expands, it faces questions on scientific rigor and regulatory oversight.

Beyond pristine beaches, Hainan is building a global trade hub. A new media tour for Hong Kong influencers reveals a deeper economic strategy at play.

Beyond the red carpet, Japan's showcase at Cannes was a calculated play for market share, blending sophisticated cultural diplomacy with aggressive business tactics.

As SpaceX makes its historic market debut, GraniteShares launches leveraged ETFs, offering traders a high-stakes way to bet on the volatile space pioneer.

Elixiron's enrupatinib shows promise in targeting neuroinflammation, with early data suggesting cognitive benefits and a new biomarker-guided path for therapy.

The recent acquisition of a thriving San Diego shopping center is more than a real estate deal. It's a test case for an ambitious plan to remake suburbia.

As Singapore's non-bank lending space heats up, Bizcap unveils a lucrative loyalty program. Is this a game-changer for SME funding or just a costly gambit?

Industrial giants struggle to scale automation beyond pilot projects. A new CEO playbook from ASI, backed by millions of autonomous miles, offers a blueprint.

For decades, patients with a rare autoimmune anemia faced a cycle of steroids and relapse. New data on a targeted therapy may finally offer a durable solution.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

As FIFA World Cup 2026 kicks off, Hisense is executing a masterclass in market disruption, using the global stage to redefine the TV landscape with RGB MiniLED.

A Korean materials firm just won a top Boeing award. We go beyond the press release to reveal how it’s fortifying global supply chains and reshaping Asia's aerospace hub.